Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas
NCT ID: NCT05947084
Last Updated: 2025-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
518 participants
INTERVENTIONAL
2023-08-31
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Growth and Tolerance of Infants Fed Formula for 16 Weeks
NCT03487094
The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants
NCT02132663
Early Iron Exposure on the Gut Microbiota in Young Infants
NCT03828708
Assessment of Growth of Infants Fed a New Formula
NCT00937014
New Infant Formula Supports Adequate Growth in Healthy Infants
NCT03614468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Formula 1_365 Day Grass-Fed Cow's Milk Infant Formula
Infant formula meets all nutrient requirements of the FDA.
Infant Formula
Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period
Study Formula 2_Goat Milk Infant Formula
Infant Formula meets all nutrient requirements of the FDA.
Infant Formula
Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period
Study Formula 3_Cow's Milk Infant Formula void of A1-BetaCasein
Infant Formula meets all nutrient requirements of the FDA.
Infant Formula
Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period
Study Formula 4_USDA Organic iron fortified infant formula
Infant Formula meets all nutrient requirements of the FDA.
Infant Formula
Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infant Formula
Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
14 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Validcare
UNKNOWN
Aussie Bubs, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Aqua, MD
Role: PRINCIPAL_INVESTIGATOR
Backtee Holdings, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Velocity Clinical Research-Phoenix
Phoenix, Arizona, United States
Advance Pediatric Associates
Centennial, Colorado, United States
Symphony Clinical Research
Jacksonville, Florida, United States
Clintheory Healthcare Miami
North Miami Beach, Florida, United States
PAS Research Tampa
Tampa, Florida, United States
UpTo Trials
Tampa, Florida, United States
Backtee Holdings, LLC
Wellington, Florida, United States
Velocity Clinical Research-Macon
Macon, Georgia, United States
Leavitt Clinical Research
Idaho Falls, Idaho, United States
Kentucky Pediatric Research
Bardstown, Kentucky, United States
Springs Medical Research
Owensboro, Kentucky, United States
Magnolia Clinical Research, LLC
Lutcher, Louisiana, United States
Velocity Clinical Research-Slidell, LA
Slidell, Louisiana, United States
Frontier Pediatric Research, LLC
Lincoln, Nebraska, United States
PAS Research Henderson
Henderson, Nevada, United States
PAS Research Vegas
Las Vegas, Nevada, United States
Velocity Clinical Research-Durham
Durham, North Carolina, United States
Hightower Clinical-Oklahoma City
Oklahoma City, Oklahoma, United States
Hightower Clinical-Shawnee
Shawnee, Oklahoma, United States
Cyn3rgy
Gresham, Oregon, United States
PAS Pittsburgh
Pittsburgh, Pennsylvania, United States
Coastal Ped Research-Charleston
Charleston, South Carolina, United States
Coastal Ped Research-Summerville
Summerville, South Carolina, United States
AVIATI Healthcare & Clinical Research
Memphis, Tennessee, United States
Helios Clinical Research-Burleson
Burleson, Texas, United States
Helios Clinical Research-Houston
Houston, Texas, United States
Prime Clinical Research, Inc
Mansfield, Texas, United States
PAS Research McAllen
McAllen, Texas, United States
Helios Clinical Research-Weatherford
Weatherford, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BubsGMS_2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.